Delayed SLND for Patients With Breast Cancer Undergoing Primary Systemic Treatment

Active, not recruitingOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

October 30, 2026

Study Completion Date

October 30, 2027

Conditions
Breast CancerChemotherapy EffectSentinel Lymph Node
Interventions
OTHER

SLND or TAD by the magnetic technique (SPIO)

All patients will receive Radioisotope according to standard of care. They will also receive SPIO in a timeframe of clinical convenience, depending on whether primary response is planned by means of MRI. For patients that are ycN0, SLND or TAD will be performed. For those that convert from cN1 to ycN0, the index lymph node will be marked with a paramagnetic marker. Axillary surgery will be undertaken with the magnetic technique and each retrieved lymph node will be controlled for radiation. Upon the completion of the procedure, a background control will be performed with the radioactive signal as guide, to ensure standard of care best practice. Any palpable lymph nodes that are not sentinels with either tracer may be removed at surgeon discretion but will be reported seperately.

Trial Locations (1)

75185

Uppsala University Hospital, Uppsala

All Listed Sponsors
collaborator

Uppsala University Hospital

OTHER

lead

Uppsala University

OTHER